Blog

Drug for recurring ER-positive breast cancer

Researchers are developing a new, first-in-class agent that has stopped the growth of estrogen receptor-positive (ER-positive) breast cancer in its tracks. The new agent is a molecule called ERX-11 that has blocked the growth of recurring breast cancer tumors. Ratna Vadlamudi, Ph.D., from UT Health San Antonio, is principal investigator of a study describing the…
Read more

Facebook
Facebook
Google+
Google+
http://www.advancedgynnj.com/blog/
INSTAGRAM
Snapchat